BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

14 related articles for article (PubMed ID: 38444679)

  • 1. Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis.
    Yang Q; Guo C; Lin X; Luo L; He Z; Lin F; Zhang J; Chen Y; Jiang X; Ke C; Mou Y
    Front Pharmacol; 2021; 12():804942. PubMed ID: 35002738
    [No Abstract]   [Full Text] [Related]  

  • 2. Anlotinib as Monotherapy or Combination Therapy for Recurrent High-Grade Glioma: A Retrospective Study.
    Yin J; Yin W; Zheng L; Li Y; Luo C; Zhang S; Duan L; Zhou H; Cheng K; Lang J; Xu K
    Clin Med Insights Oncol; 2023; 17():11795549231175714. PubMed ID: 37435019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis.
    Shen F; Li J; Liu F; Sun N; Qiu X; Ding W; Sun X
    Front Oncol; 2023; 13():1095362. PubMed ID: 36874124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial.
    Zhao S; Zhang M; Zhang Q; Wu J; Dai H
    BMC Cancer; 2024 Jan; 24(1):6. PubMed ID: 38166698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction: ZNF655 promotes the progression of glioma through transcriptional regulation of AURKA.
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1294900. PubMed ID: 38023237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis.
    Frontiers Editorial Office
    Front Oncol; 2024; 14():1383410. PubMed ID: 38444679
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.